Larry Fong

Advisor at Soteria

Larry Fong, MD is the Efim Guzik Distinguished Professor in Cancer Biology and leads the Cancer Immunotherapy Program at the UCSF. He co-directs the Parker Institute of Cancer Immunotherapy at UCSF and co-leads the Cancer Immunity Program in the Helen Diller Family Comprehensive Cancer Center. He is a physician-scientist in the Department of Medicine, Division of Hematology/Oncology directing both a translational research program and a research lab. He has focused on cancer immunotherapy for over 20 years and has been involved in both pre-clinical and clinical studies of FDA-approved immunotherapies including sipuleucel-T and immune checkpoint inhibitors. Dr. Fong’s research focuses on understanding the mechanisms that underlie clinical response and resistance to immunotherapies.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Soteria

Soteria is a biotechnology company that develops immunotherapies to treat cancer patients


Industries

Employees

1-10

Links